6 terminated. 6 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Terminated 6 |
Follow Lung Diseases, Obstructive: new trials by email Literature Review of Lung Diseases, Obstructive trials Research Report on Lung Diseases, Obstructive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD) MitoQ, Placebo - Chronic Obstructive Pulmonary Disease | Early Phase 1 | Terminated | Virginia Commonwealth University | 4 | 2023-02-16 | 2025-02-27 |
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection | Early Phase 1 | Terminated | Thunder Bay Regional Health Research Institute | 10 | 2020-11-10 | 2024-10-15 |
| Screening Inhaled Allergen Challenge for Dermatophagoides Farinae Der f - Asthma | Early Phase 1 | Terminated | University of North Carolina, Chapel Hill | 14 | 2018-01-29 | 2022-10-18 |
| Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen Inhaled Nitric Oxide 30mcg/kg IBW/hr - COPD, Pulmonary Hypertension | Early Phase 1 | Terminated | Bellerophon | 7 | 2016-10-01 | 2023-02-21 |
| Asthma & COPD Guideline Implementation Standard Practice Group (SPG), TISG - Asthma, Chronic Obstructive Pulmonary Disease | Early Phase 1 | Terminated | Laval University | 92 | 2009-09-01 | 2013-01-11 |
| Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) Regadenoson, Dobutamine - Coronary Artery Disease, Asthma | Early Phase 1 | Terminated | Wake Forest University Health Sciences | 14 | 2009-01-01 | 2018-09-26 |
Pulmonary Disease, Chronic Obstructive (5) · Asthma (4) · Hypertension, Pulmonary (2) · Angina Pectoris (1) · Asbestosis (1) · Bronchiectasis (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Cystic Fibrosis (1) · Emphysema (1) · Lung Diseases, Interstitial (1) · Lung Neoplasms (1) · Mesothelioma (1) · Myocardial Ischemia (1) · Pulmonary Embolism (1)
Lung Diseases (6) · Respiratory Tract Diseases (6) · Chronic Disease (5) · Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Bronchial Diseases (4) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Respiratory Hypersensitivity (4) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Hypertension (2)
Antigens, Dermatophagoides (1) · Dobutamine (1) · Inosine (1) · Sulfur Hexafluoride (1) · mitoquinone (1) · perflutren (1) · regadenoson (1)
Bellerophon (1) · Laval University (1) · Thunder Bay Regional Health Research Institute (1) · University of North Carolina, Chapel Hill (1) · Virginia Commonwealth University (1) · Wake Forest University Health Sciences (1)
United States (3) · Canada (2) · Belgium (1)
Ashika Ahmed, MD (1) · Louis-Philippe Boulet, MD, FRCPC (1) · Michelle Hernandez, MD (1) · Mitchell S Albert, PhD (1) · Paula Rodriguez-Miguelez, PhD (1) · William G Hundley, M.D., F.A.C.C., F.A.H.A (1)
R01HL135235 (1)